Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II, Multi-Center, Open-Label Study of VT3989, Alone or in Combination, in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04665206 is registered in ClinicalTrials.gov with Vivace Therapeutics, Inc as lead sponsor.

NCT NCT04665206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04665206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II, Multi-Center, Open-Label Study of VT3989, Alone or in Combination, in Patients With Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Vivace Therapeutics, Inc
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 24, 2021
Completion date
March 2, 2030
Enrollment
434 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma, nsclc, solid tumor, adult